A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches
This study has been terminated.
(Failure to recruit necessary number of patients.)
Sponsor:
Charlottesville Neuroscience
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Patricia Shipley, MD, Charlottesville Neuroscience
ClinicalTrials.gov Identifier:
NCT00391755
First received: October 22, 2006
Last updated: February 8, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | October 2009 |
| Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |